Follow
Liquid Biopsy
A liquid biopsy is a diagnostic test using liquid biological samples. Considered non-invasive, it can be used to track cancers, heart issues, and do prenatal diagnosis.
-
APR 02, 2024 | 8:00 AM
Circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) have each gained attention as promising liquid biopsy markers, offering molecular insights into cancer progression, overall s...MAR 21, 2024 | 10:00 AM
Next-generation sequencing (NGS) based liquid biopsy is emerging as standard of care in oncology for comprehensive genomic profiling (CGP) of solid tumors. In this presentation we will showc...DEC 12, 2023 | 7:00 AM
An estimated 48.5 million couples suffer from infertility worldwide, driving up usage of assisted reproductive technologies around the globe. As a result, preimplantation genetic testing (PG...Speaker: Anil Biricik, PhD , Sandrine Chamayou, PhD , Prof. Volkan Baltaci, MD, PhD , Alok Tomar, PhDSponsored By: Thermo Fisher ScientificNOV 30, 2023 | 12:00 PMC.E. CREDITS
Pathology Perspective: Discover the critical need for genomic testing in cancer and explore the differences between traditional tissue biopsies and liquid genomic profiling. We'll dive i...Speaker: Dr. Shuko Harada , Dr. Aakash Desai, MBBS, MPHPresented at: Precision Medicine in Solid Tumors
NOV 29, 2023 | 9:00 AM
Tumor genomic profiling can be complicated, especially for diseases that commonly have multiple different genomic biomarkers of interest, such as non-small cell lung cancer (NSCLC) and color...OCT 24, 2023 | 9:00 AM
DNA comprises molecular information stored in genetic and epigenetic bases, both of which are vital to our understanding of biology in health and disease. The interaction of genetics with th...SEP 13, 2023 | 10:00 AM
Liquid biopsy is an emerging area of clinical research, particularly in the context of cancer. As a minimally invasive complementary or alternative approach to tissue biopsies, liquid biopsi...Speaker: Dr. Eloisa Jantus Lewintre, PhD , Dr. Gorka Alkorta-Aranburu , Matteo Allegretti, PhDPresented at: The Future of Cutting-Edge Genomic Technologies for Liquid Biopsy Cancer Research
Sponsored By: Thermo Fisher ScientificSeptember 13 at 10:00am CEST, 9:00am BST
Webinar airing too early or too late for you? This webinar will also be available: September 13 at 10:00am PDT, 1:00pm EDT https://www.labroots.com/ms/webinar/dpcr-liquidbiopsy-panel-2 and S...Speaker: Dr. Eloisa Jantus Lewintre, PhD , Dr. Gorka Alkorta-Aranburu , Matteo Allegretti, PhDPresented at: The Future of Cutting-Edge Genomic Technologies for Liquid Biopsy Cancer Research
Sponsored By: Thermo Fisher ScientificSeptember 13 at 9:30am IST, 12:00pm CST/SGT
Liquid biopsy is an emerging area of clinical research, particularly in the context of cancer. As a minimally invasive complementary or alternative approach to tissue biopsies, liquid biopsi...Speaker: Dr. Eloisa Jantus Lewintre, PhD , Dr. Gorka Alkorta-Aranburu , Matteo Allegretti, PhDPresented at: The Future of Cutting-Edge Genomic Technologies for Liquid Biopsy Cancer Research
Sponsored By: Thermo Fisher ScientificJuly 18, 2023 12:30PM EDTC.E. CREDITS
Lung cancer is still responsible for most cancer-related deaths for both genders in the United States. Traditionally, diagnosis and management of patients has been based on tissue biopsy to...JUN 27, 2023 | 11:00 AMC.E. CREDITS
Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths, according to the World Health Organization. Many cancers can be cu...JUN 15, 2023 | 7:00 AM
Liquid biopsies represent a transformation in the management of cancer as they have the potential to detect, characterize, and monitor cancers earlier than can be achieved with conventional...APR 25, 2023 | 10:00 AMC.E. CREDITS
Date: April 25, 2023 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) A liquid biopsy is a non-invasive alternative to a surgical biopsy that enables researchers to learn a range of infor...MAR 30, 2023 | 1:00 PMC.E. CREDITS
The circulating T-cell receptor (TCR) repertoire is a dynamic representation of overall immune responses in an individual. Here we aimed to correlate pre-treatment circulating TCR repertoire...Speaker: Elin Gray, BSc, MSc, PhDPresented at: OncomineWorld 2023: A Virtual NGS Education Meeting
MAR 30, 2023 | 1:00 PM
The circulating T-cell receptor (TCR) repertoire is a dynamic representation of overall immune responses in an individual. Here we aimed to correlate pre-treatment circulating TCR repertoire...Speaker: Elin Gray, BSc, MSc, PhDPresented at: OncomineWorld 2024: A Virtual NGS Education Meeting
MAR 30, 2023 | 12:25 PMC.E. CREDITS
Next-generation sequencing can detect multiple driver oncogenes simultaneously, enabling the analysis of limited amounts of biopsied tissue samples. . Druggable driver mutations cover more t...MAR 30, 2023 | 12:25 PM
Next-generation sequencing can detect multiple driver oncogenes simultaneously, enabling the analysis of limited amounts of biopsied tissue samples. . Druggable driver mutations cover more t...MAR 30, 2023 | 12:05 PMC.E. CREDITS
In this study, we evaluated the concordance of targeted sequencing results between paired ctDNA and tumor samples from early breast cancers scheduled for curative surgery with or without adj...Speaker: Dr. Chi-Cheng Huang, PhDPresented at: OncomineWorld 2023: A Virtual NGS Education Meeting
MAR 30, 2023 | 12:05 PM
In this study, we evaluated the concordance of targeted sequencing results between paired ctDNA and tumor samples from early breast cancers scheduled for curative surgery with or without adj...Speaker: Dr. Chi-Cheng Huang, PhDPresented at: OncomineWorld 2024: A Virtual NGS Education Meeting
MAR 01, 2023 | 8:00 AM
Date: March 01, 2023 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET) Characterizing metastasis remains key for understanding and eradicating cancer. The study of circulating tumor cells (CTC...FEB 21, 2023 | 10:00 AM
Date: February 21, 2023 Time: 10:00am (PST), 1:00pm (EST), 7:00pm (CET) The use of algorithms that alter patient medical care based on race has fallen under increasing criticism, as race-bas...DEC 08, 2022 | 9:00 AM
Date: December 8, 2022 Time: 9:00am (PST), 12:00pm (EST), 6:00pm (CET) Liquid biopsy enables non-invasive testing and monitoring in oncology, but also comes with unique challenges. In this...APR 21, 2022 | 5:30 AM
Up until now, Big Data in healthcare has failed to drive any real progress in curing disease. However, we have just now reached a cost and throughput threshold in sequencing and bioinformati...FEB 23, 2022 | 6:00 AM
Cancer still accounts for nearly 1 in every 4 deaths worldwide. New immunotherapies have the power to induce durable responses in patients with fatal cancers, but only a small percentage of...Speaker: Hans-Dieter Zucht, PhDPresented at: Drug Discovery & Development Virtual Event Series 2022
Sponsored By: Luminex - A DiaSorin Company
APR 02, 2024 | 8:00 AM
Circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) have each gained attention as promising liquid biopsy markers, offering molecular insights into cancer progression, overall s...
MAR 21, 2024 | 10:00 AM
Next-generation sequencing (NGS) based liquid biopsy is emerging as standard of care in oncology for comprehensive genomic profiling (CGP) of solid tumors. In this presentation we will showc...
DEC 12, 2023 | 7:00 AM
An estimated 48.5 million couples suffer from infertility worldwide, driving up usage of assisted reproductive technologies around the globe. As a result, preimplantation genetic testing (PG...
Speaker:
Anil Biricik, PhD
, Sandrine Chamayou, PhD
, Prof. Volkan Baltaci, MD, PhD
, Alok Tomar, PhD
Sponsored By: Thermo Fisher Scientific
NOV 30, 2023 | 12:00 PM
C.E. CREDITS
Pathology Perspective: Discover the critical need for genomic testing in cancer and explore the differences between traditional tissue biopsies and liquid genomic profiling. We'll dive i...
Speaker:
Dr. Shuko Harada
, Dr. Aakash Desai, MBBS, MPH
Presented at: Precision Medicine in Solid Tumors
NOV 29, 2023 | 9:00 AM
Tumor genomic profiling can be complicated, especially for diseases that commonly have multiple different genomic biomarkers of interest, such as non-small cell lung cancer (NSCLC) and color...
OCT 24, 2023 | 9:00 AM
DNA comprises molecular information stored in genetic and epigenetic bases, both of which are vital to our understanding of biology in health and disease. The interaction of genetics with th...
SEP 13, 2023 | 10:00 AM
Liquid biopsy is an emerging area of clinical research, particularly in the context of cancer. As a minimally invasive complementary or alternative approach to tissue biopsies, liquid biopsi...
Speaker:
Dr. Eloisa Jantus Lewintre, PhD
, Dr. Gorka Alkorta-Aranburu
, Matteo Allegretti, PhD
Presented at: The Future of Cutting-Edge Genomic Technologies for Liquid Biopsy Cancer Research
Sponsored By: Thermo Fisher Scientific
Sponsored By: Thermo Fisher Scientific
September 13 at 10:00am CEST, 9:00am BST
Webinar airing too early or too late for you? This webinar will also be available: September 13 at 10:00am PDT, 1:00pm EDT https://www.labroots.com/ms/webinar/dpcr-liquidbiopsy-panel-2 and S...
Speaker:
Dr. Eloisa Jantus Lewintre, PhD
, Dr. Gorka Alkorta-Aranburu
, Matteo Allegretti, PhD
Presented at: The Future of Cutting-Edge Genomic Technologies for Liquid Biopsy Cancer Research
Sponsored By: Thermo Fisher Scientific
Sponsored By: Thermo Fisher Scientific
September 13 at 9:30am IST, 12:00pm CST/SGT
Liquid biopsy is an emerging area of clinical research, particularly in the context of cancer. As a minimally invasive complementary or alternative approach to tissue biopsies, liquid biopsi...
Speaker:
Dr. Eloisa Jantus Lewintre, PhD
, Dr. Gorka Alkorta-Aranburu
, Matteo Allegretti, PhD
Presented at: The Future of Cutting-Edge Genomic Technologies for Liquid Biopsy Cancer Research
Sponsored By: Thermo Fisher Scientific
Sponsored By: Thermo Fisher Scientific
July 18, 2023 12:30PM EDT
C.E. CREDITS
Lung cancer is still responsible for most cancer-related deaths for both genders in the United States. Traditionally, diagnosis and management of patients has been based on tissue biopsy to...
JUN 27, 2023 | 11:00 AM
C.E. CREDITS
Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths, according to the World Health Organization. Many cancers can be cu...
JUN 15, 2023 | 7:00 AM
Liquid biopsies represent a transformation in the management of cancer as they have the potential to detect, characterize, and monitor cancers earlier than can be achieved with conventional...
APR 25, 2023 | 10:00 AM
C.E. CREDITS
Date: April 25, 2023 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) A liquid biopsy is a non-invasive alternative to a surgical biopsy that enables researchers to learn a range of infor...
MAR 30, 2023 | 1:00 PM
C.E. CREDITS
The circulating T-cell receptor (TCR) repertoire is a dynamic representation of overall immune responses in an individual. Here we aimed to correlate pre-treatment circulating TCR repertoire...
Speaker:
Elin Gray, BSc, MSc, PhD
Presented at: OncomineWorld 2023: A Virtual NGS Education Meeting
MAR 30, 2023 | 1:00 PM
The circulating T-cell receptor (TCR) repertoire is a dynamic representation of overall immune responses in an individual. Here we aimed to correlate pre-treatment circulating TCR repertoire...
Speaker:
Elin Gray, BSc, MSc, PhD
Presented at: OncomineWorld 2024: A Virtual NGS Education Meeting
MAR 30, 2023 | 12:25 PM
C.E. CREDITS
Next-generation sequencing can detect multiple driver oncogenes simultaneously, enabling the analysis of limited amounts of biopsied tissue samples. . Druggable driver mutations cover more t...
MAR 30, 2023 | 12:25 PM
Next-generation sequencing can detect multiple driver oncogenes simultaneously, enabling the analysis of limited amounts of biopsied tissue samples. . Druggable driver mutations cover more t...
MAR 30, 2023 | 12:05 PM
C.E. CREDITS
In this study, we evaluated the concordance of targeted sequencing results between paired ctDNA and tumor samples from early breast cancers scheduled for curative surgery with or without adj...
Speaker:
Dr. Chi-Cheng Huang, PhD
Presented at: OncomineWorld 2023: A Virtual NGS Education Meeting
MAR 30, 2023 | 12:05 PM
In this study, we evaluated the concordance of targeted sequencing results between paired ctDNA and tumor samples from early breast cancers scheduled for curative surgery with or without adj...
Speaker:
Dr. Chi-Cheng Huang, PhD
Presented at: OncomineWorld 2024: A Virtual NGS Education Meeting
MAR 01, 2023 | 8:00 AM
Date: March 01, 2023 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET) Characterizing metastasis remains key for understanding and eradicating cancer. The study of circulating tumor cells (CTC...
FEB 21, 2023 | 10:00 AM
Date: February 21, 2023 Time: 10:00am (PST), 1:00pm (EST), 7:00pm (CET) The use of algorithms that alter patient medical care based on race has fallen under increasing criticism, as race-bas...
DEC 08, 2022 | 9:00 AM
Date: December 8, 2022 Time: 9:00am (PST), 12:00pm (EST), 6:00pm (CET) Liquid biopsy enables non-invasive testing and monitoring in oncology, but also comes with unique challenges. In this...
APR 21, 2022 | 5:30 AM
Up until now, Big Data in healthcare has failed to drive any real progress in curing disease. However, we have just now reached a cost and throughput threshold in sequencing and bioinformati...
FEB 23, 2022 | 6:00 AM
Cancer still accounts for nearly 1 in every 4 deaths worldwide. New immunotherapies have the power to induce durable responses in patients with fatal cancers, but only a small percentage of...
Speaker:
Hans-Dieter Zucht, PhD
Presented at: Drug Discovery & Development Virtual Event Series 2022
Sponsored By: Luminex - A DiaSorin Company
Sponsored By: Luminex - A DiaSorin Company